1. Home
  2. Live Updates
  3. Hepatocellular carcinoma

Live Breaking News & Updates on Hepatocellular carcinoma

Stay informed with the latest breaking news from Hepatocellular carcinoma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Hepatocellular carcinoma and stay connected to the pulse of your community

ASCO Updates Advanced HCC Treatment Guideline

ASCO has announced a guideline update for systemic therapy in advanced hepatocellular carcinoma.

United-states , Connecticut , New-haven , American , Johnd-gordan , Michalg-rose , American-society-of-clinical-oncology , Yale-school-of-medicine , Veterans-affairs-comprehensive-cancer-center , Va-connecticut-health-care-system , American-society

Baseline Enrollment Completed for AMRA Medical and Linköping University's Landmark Liver Disease Study

Baseline Enrollment Completed for AMRA Medical and Linköping University's Landmark Liver Disease Study
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Sweden , Swedish , Mattias-ekstedt , Linkedin , University-landmark-liver-disease-study , Enrollment-completed , Landmark-liver-disease , Clinical-surveillance , Portal-hypertension , Hepatocellular-carcinoma , End-stage-liver-disease , Business-wire

Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information

Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China , United-states , Spain , France , Paris , France-general- , Chinese , French , Lcs-cade-cadx , Caroline-carmagnol , Emmanuelle-leygues , Ghislaine-gasparetto

Dr Amit Singal on Populations at Risk for HCC and When Screening Is Needed

Amit Singal, MD, medical director of the UT Southwestern Medical Center Liver Tumor Program, discusses populations at the highest risk of hepatocellular carcinoma (HCC), when screening is needed, and key tools in HCC surveillance and screening.

Amit-singal , Ben-franklin , Liver-tumor-program , Ut-southwestern-medical-center , Medical-center , Hepatocellular-carcinoma , Hcc , Liver-cancer , Liver-cancer-screening ,

How liver transplant can save the lives of those suffering from liver diseases

If you have severe and chronic liver diseases such as liver cirrhosis or liver cancer, a liver transplant can be life-saving for you

Mumbai , Maharashtra , India , Gaurav-chaubal , Gleneagles-hospitals , Hepatocellular-carcinoma , Acute-liver-failure , Whatsapp-channels , Liver-transplant , Iver-diseases , Ive-conditions

HCC Trials: Insights from the LAUNCH, EMERALD-1, and LEAP-012 Trials

Medical experts discuss the LAUNCH study, EMERALD-1, and LEAP-012 trials, providing updates on the progress and findings that influence the treatment paradigm for hepatocellular carcinoma.

Tyrosine-kinase-inhibitors , Unresectable-hepatocellular-carcinoma , Hepatocellular-carcinoma , Hcc , Tace , Transarterial-chemoembolization , Lenvatinib , Launch-study , Emerald-1-study , Durvalumab , Bevacizumab

Dr Michael Morse on the Etiologies of HCC and Treatment Options for Patients With Worsening Liver Function

Michael Morse, MD, FACP, MHS, professor of medicine at Duke University School of Medicine and medical oncologist at Duke Cancer Center, discusses the etiologies of hepatocellular carcinoma (HCC) and how clinicians can tailor treatment for patients with varied levels of liver function.

Japan , Michael-morse , Duke-cancer-center , Duke-university-school-of-medicine , Duke-university-school , Hepatocellular-carcinoma , Liver-function , Cirrhosis , Child-pugh-a ,

Combining Liver-directed and Systemic Therapies in HCC

The impact of compounding liver-directed and systemic therapies in HCC management is discussed by Drs Morse and Covey.

Evolving-treatments , Hepatocellular-carcinoma , Systemic-therapies , Hcc-treatment , Liver-cancer-therapy , Interventional-radiologist-role , Liver-directed-therapy , Transarterial-chemoembolization-tace- , Transarterial-radioembolization-tare- , Systemic-therapy-for-hcc , Tkis-in-hcc

Patient Profile 2: Patient Progression After Frontline HCC Therapy

Drs Saeed and Shroff discuss the next patient profile, focusing on HCC treatment strategies following disease progression after first-line therapy.

Evolving-treatments , Hepatocellular-carcinoma , Patient-progression-after-frontline ,

HCC Treatment Strategy Driven by Real-World Evidence

Real-world evidence (RWE) provides critical knowledge for providers constructing a treatment regimen for patients diagnosed with hepatocellular carcinoma.

Evolving-treatments , Hepatocellular-carcinoma , Strategy-driven , Real-world-evidence , Hcc-treatment , Liver-cancer-therapy , Interventional-radiologist-role , Liver-directed-therapy , Transarterial-chemoembolization-tace- , Transarterial-radioembolization-tare- , Systemic-therapy-for-hcc